Oral OTEZLA (Apremilast) monotherapy shows long-term clinical benefits
Clinically meaningful improvements in enthesitis, dactylitis and physical function with OTEZLA seen at week 16
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.